Loading…
Lobbying Spend
—
Filings
33
Firms Hired
2
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed CY hospital outpatient and post acute rules.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2026 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing and proposed rules under H.R. 1; issues related to proposals affecting site of service payment differentials; issues related to Rural Health Transformation Fund; issues related to treatment of nurse education loan allowances and nurse shortage issues generally; issues related to Medicare payment for radiation oncology services; issues related to tax exempt hospital reporting obligations; issues related to proposed FY 27 rules for inpatient hospital prospective payment system.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
Client expense: — · Firm income: $90,000
Matched citations: H.R.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; issues related to mandatory program extender policies including delaying Medicaid DSH reductions and telehealth waiver extensions; issues related to Rural Health Transformation Fund; H.R.1, One Big Beautiful Bill Act
Client expense: — · Firm income: $90,000
Matched citations: H.R.1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Medicaid program financing; issues related to continuous coverage of Marketplace insurance; CMS final rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; related to mandatory program extender policies including delaying Medicaid DSH reductions; issues related to HRSA 340B program; H.R. 1, One Big Beautiful Bill Act.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 1
Lower Costs, More Transparency Act
2024 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2024 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Bipartisan Primary Care and Health Workforce Act
2024 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Bipartisan Primary Care and Health Workforce Act
2024 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program, government funding and continuing resolutions.
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Bipartisan Primary Care and Health Workforce Act
2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Bipartisan Primary Care and Health Workforce Act
2024 · third_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS proposed rules on improving organ transplant access; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to mandatory program extender policies including delaying Medicaid Disproportionate Share Hospitals (DSH) reductions; issues related to Health Resources and Services Administration (HRSA) 340B program.
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to FY 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2024 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Fy 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Bipartisan Primary Care and Health Workforce Act
2024 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to FY 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Bipartisan Primary Care and Health Workforce Act
2024 · second_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to Fy 2025 CMS Proposed IPPS rule; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Lower Costs, More Transparency Act
2024 · first_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Lower Costs, More Transparency Act
2024 · first_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Bipartisan Primary Care and Health Workforce Act
2024 · first_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Bipartisan Primary Care and Health Workforce Act
2024 · first_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act; issues related to cancer treatment and radiation oncology.
Client expense: — · Firm income: $90,000
Matched citations: S. 2840
Lower Costs, More Transparency Act
2023 · fourth_quarter · Firm: FEDERAL HEALTH POLICY STRATEGIES
Issues related to CMS final rules governing Outpatient Protective Payment Systems (OPPS), Physician Fee Schedule (PFS) and 340B remedies; issues related to hospital transparency and health care consolidation under review by House Energy and Commerce Committee, House Ways and Means Committee, and Senate Finance Committee; issues related to cancer drug shortages; issues related to proposals affecting site of service payment differentials; H.R. 5378, Lower Costs, More Transparency Act; S. 2840, Bipartisan Primary Care and Workforce Act
Client expense: — · Firm income: $90,000
Matched citations: H.R. 5378
Source: Senate LDA